Forbes April 24, 2024
Drug shortages are at an all-time high. Earlier this month, the White House rolled out a plan intended to sharply reduce future shortages of essential medicines, such as antibiotics and cancer drugs.
While I applaud the administration’s determination, I am concerned that its plan ignores the main cause of drug shortages: the variable quality of America’s generic drug supply, much of which is imported from overseas.
Neera Tanden, President Biden’s domestic policy adviser, said in an interview with Bloomberg News that the administration wants to “Address the market failure that currently exists, which is that there is no entity that’s accountable to [maintain the] supply chain. Today, when we have a drug shortage, various entities within the healthcare system point...
Today's Sponsors
Today's Sponsor